Characterized by their antioxidant, anti‐inflammatory properties, and the ability to inhibit cell proliferation, PONs demonstrate therapeutic potential in CNS disorders, heart disease, and cancer.[46] Among them, Pon3 is predominantly hepatically‐derived, undergoing systemic distribution via apolipoprotein/HDL complexes to target tissues. The gene discussed is PON3; the disease is cancer.